Riluzole–Triazole Hybrids as Novel Chemical Probes for Neuroprotection in Amyotrophic Lateral Sclerosis
yes === Despite intense attention from biomedical and chemical researchers, there are few approved treatments for amyotrophic lateral sclerosis (ALS), with only riluzole (Rilutek) and edaravone (Radicava) currently available to patients. Moreover, the mechanistic basis of the activity of these drugs...
| Main Authors: | , , , |
|---|---|
| Language: | en |
| Published: |
2018
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10454/16574 |